期刊文献+

单纯淋球菌感染与淋球菌混合其他病原体感染患者的治疗分析 被引量:5

Therapeutic effects in patients with single gonococcal infection or with infections of gonococci mixed with other pathogens
在线阅读 下载PDF
导出
摘要 目的观察和比较"中国疾病预防控制中心"制定的治疗方案(常规方案)对单纯淋球菌感染和淋球菌混合其他病原体感染患者的治疗效果。方法收集32例单纯淋球菌感染患者和50例混合病原体感染患者(淋球菌合并沙眼衣原体或解脲支原体或梅毒螺旋体感染)的临床资料,回顾患者经常规方案治疗的效果,比较单纯淋球菌感染与混合病原体感染患者临床痊愈所需时间(接受常规方案至获得临床痊愈的时间)。结果所有患者的总体痊愈率为92.4%,其中单纯淋球菌感染患者均获得临床痊愈,混合病原体感染患者的临床痊愈率为84.0%。单纯淋球菌感染和淋球菌混合其他病原体感染患者临床痊愈所需时间平均为(9.4±1.8)d和(9.7±2.3)d,两者比较差异无统计学意义(P>0.05)。结论接受常规方案治疗的淋球菌混合其他病原体感染患者的临床痊愈时间与单纯淋球菌感染患者相当,提示常规方案亦适用于混合病原体感染患者。 Objective To investigate the therapeutic effects of regimen designed by Chinese Center for Disease Control and Prevention (conventional regimen) on patients with single gonococcal infection or with infections of gonococci mixed with other pathogens. Methods The clinical data of 32 patients with single gonococcal infection and 50 patients with gonococcal infection mixed with the other pathogen infection (gonococcal infection mixed with Chlamydia trachomatis infection, mycoplasma urealytium infection or treponema pallidum infection) were collected, the therapeutic effects of conventional regimen were retrospectively analysed, and time spent for clinical recovery (from the initiation of conventional regimen to clinical recovery) was compared between patients with single gonococcal infection and those with gonococcal infection mixed with the other pathogen infection. Results The total clinical recovery rate was 92.4%, with 100% for patients with single gonococcal infection and 84.0% for those with gonococcal infection mixed with the other pathogen infection. Time spent for clinical recovery for patients with single gonococcal infection and those with gonococcal infection mixed with the other pathogen infection was (9.4±1.8) d and (9.7±2.3) d, respectively, and there was no significant difference between them (P〉0.05). Conclusion Time spent for clinical recovery for patients with gonococcal infection mixed with the other pathogen is similar to that for patients with single gonococcal infection, indicating that conventional regimen is also suitable to patients with gonococcal infection mixed with the other pathogen infection.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第7期874-876,共3页 Journal of Shanghai Jiao tong University:Medical Science
关键词 淋病 混合感染 沙眼衣原体 解脲支原体 梅毒螺旋体 gonorrhea mixed infection Chlamydia trachomatis mycoplasma urealytium treponema pallidum
  • 相关文献

参考文献8

二级参考文献23

  • 1肖嵘,文海泉,曹成海,苏玉文,甘小燕,周怡新,张静,李干群,周英,颜兰香.2002年湖南地区性病门诊患者支原体感染情况调查及药敏结果分析[J].临床皮肤科杂志,2003,32(8):451-452. 被引量:53
  • 2曹佩霞,黄瑞萍,郑亚芬,承晓京,汤韧.淋病奈瑟菌分离株3种药物耐药基因检测[J].临床皮肤科杂志,2003,32(12):703-704. 被引量:2
  • 3罗德梅,淑文,董潇阳,惠艳.乌鲁木齐地区STD门诊患者支原体的检测与药敏分析[J].中国皮肤性病学杂志,2004,18(12):739-740. 被引量:12
  • 4Belear CM,Renaudin H.In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Urealyticum fluoroquinoloneresistant isolates that have been genetically characterized[J].Antimicrob Agents Chemother,2000,44 (9):2557-2560.
  • 5君跃平,苏晓红,尚淑贤,等.美国性传播疾病治疗指南(中文版).北京:中国医学科学院皮肤病研究所翻印,2002.73.
  • 6Bebear CM, Bove JM, Bebear C,et al. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones [ J ]. Antimicrobal Agent Chemother, 1997,41 (2) :269 - 273.
  • 7Bebear CM, Renaudin H, Charron A, et al. In vitro activity of trovalloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinoloneresistant isolates that have been genetically c
  • 8王剑 吴明江.性病艾滋病防治培训教材[M].北京:北京医科大学出版社,1999.60-89.
  • 9Centers for Disease Control and Prevention Sexually transmitted diseasestreatment guidelines 2002[J].MMWR,2002,51 (RR-6):36-42.
  • 10World Health Organization (WHO).Guidelines for the management of sexually transmitted infections[M].WHO/HIV-AIDS/2001.11.Geneva:World Health Organization,2001.32-33.

共引文献705

同被引文献39

  • 1杨健,杨文林,黄新宇.支原体耐药性与抗菌药消耗量相关性研究[J].药物流行病学杂志,2005,14(3):156-158. 被引量:6
  • 2刘晓华,陈永康,杨玉声,张建伟,董建雄.泌尿生殖道支原体检测结果及药敏分析[J].中国药师,2006,9(5):451-452. 被引量:1
  • 3李航,胡正波.非淋菌性尿道炎(宫颈炎)的药物治疗[J].中国药师,2007,10(2):172-174. 被引量:9
  • 4Mann TA, Uddin Z, Hendriks AM, et al. Get Tested Why Not? A Novel Approach to Intemet - based Chlamydia and Gonorrhea Testing in Canada. Can J Public Health, 2013 , 104(3) :205 -209.
  • 5Manos MM, Darbinian J, Rubin J, et al. The effect of hepa- titis C treatment response on medical costs: a longitudinal analysis in an integrated care setting. :I Manag Care Pharm, 2013 ,19(6) :438 -447.
  • 6arrasco JL, Alvarez E, Olivares JM, et al. A comparative cost - analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine- resistant patients with generalized anxiety disorder in Spain. Actas Esp Psiquiatr,2013 ,41 (3) :164 - 174.
  • 7Macaluso A, Bernabucci M, Trabucco A, et al. Analgesic effect of a single preoperative dose of the antibiotic ceftriax- one in humans. J Pain,2013 ,14(6) :604-612.
  • 8Crandon JL, Nicolau DP. Human Simulated Studies of Aztre- onam and Aztreonam - Avibactam To Evaluate Activity a- gainst Challenging Gram - Negative Organisms, Including Metallo - β - Lactamase Producers. Antimicrob Agents Che- mother,2013 .57 (7 ) :3299 - 3306.
  • 9Pugsley RA, Chapman DA, Kennedy MG, et al. Residential segregation and gonorrhea rates in US metropolitan statisti- cal areas, 2005 -2009. Sex Transm Dis,2013 ,40(6) : 439 - 443.
  • 10Fantasia HC. Updated treatment guidelines for gonorrhea in- fections. Nurs Womens Health,2013,17 (3) :231 - 235.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部